Property:DocSubmittedBy
From GxPlex
Name of the person who submitted this entry.
U
Florian Adragna +
USA FDA Guidance for Industry - Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Aug-2013 +
Florian Adragna +
USA FDA Guidance for Industry Investigator Responsibilities — Protecting the Rights, Safety, and Welfare of Study Subjects Oct-2009 +
Florian Adragna +
USA FDA INFORMATION SHEET - Recruiting Study Subjects, Guidance for Institutional Review Boards and Clinical Investigators Jan-1998 +
Florian Adragna +
Florian Adragna +
Florian Adragna +
Florian Adragna +
USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 +
Florian Adragna +
Florian Adragna +
Florian Adragna +
Florian Adragna +
Florian Adragna +
Florian Adragna +
C
CIOMS CIOMS - International Ethical Guidelines for Biomedical Research Involving Human Subjects 2016 +
Florian Adragna +
Florian Adragna +
Florian Adragna +
I
Florian Adragna +
Florian Adragna +
Florian Adragna +
Florian Adragna +
